Mood stabilizer psychopharmacology
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lithium inhibits a number of enzymes, including glycogen synthase kinase-3β (GSK-3β) and IMPase (Gould et al., 2002; Coyle and Duman, 2003).”
From Lithium induces autophagy by inhibiting inositol monophosphatase (2005) · cites this paper as Gould et al., 2002
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wnt signaling: a common theme in animal development
Cadigan, K. M., & Nusse, R. (1997) · Genes & Development · doi:10.1101/gad.11.24.3286 · Cited by 2,567
Neurotrophins as synaptic modulators
Poo, M.-M. (2001) · Nature Reviews Neuroscience · doi:10.1038/35049004 · Cited by 1,775
Phiel, C. J., Zhang, F., Huang, E. Y., Guenther, M. G., Lazar, M. A., & Klein, P. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101287200 · Cited by 1,758
The cellular neurobiology of depression
Manji, H. K., Drevets, W. C., & Charney, D. S. (2001) · Nature Medicine · doi:10.1038/87865 · Cited by 1,182
Self-citationBowden, C. L. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.5.481 · Cited by 678
PSYCHONEUROENDOCRINOLOGY OF DEPRESSION
Plotsky, P. M., Owens, M. J., & Nemeroff, C. B. (1998) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70006-x · Cited by 672
Lithium-induced increase in human brain grey matter
Moore, G. J., Bebchuk, J. M., Wilds, I. B., Chen, G., & Menji, H. K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02793-8 · Cited by 649
Self-citationEndophenotypes in bipolar disorder
Lenox, R. H., Gould, T. D., & Manji, H. K. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10360 · Cited by 264
Self-citationMorphological Brain Changes in Depression: Can Antidepressants Reverse Them?
Miguel-Hidalgo, J. J., & Rajkowska, G. (2002) · CNS Drugs · doi:10.2165/00023210-200216060-00001 · Cited by 64
Research works printed but not linked: 224
- Manji, 1999, Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications, J Clin Psychiatry, 60, 27
- Gould, 2002, Signaling networks in the pathophysiology and treatment of mood disorders, J Psychosom Res, 53, 687, 10.1016/S0022-3999(02)00426-9 · DOI
- Manji, 2000, Signaling: cellular insights into the pathophysiology of bipolar disorder, Biol Psychiatry, 48, 518, 10.1016/S0006-3223(00)00929-X · DOI · Paper page
- Waldmeier, 1987, Is there a common denominator for the antimanic effect of lithium and anticonvulsants?, Pharmacopsychiatry, 20, 37, 10.1055/s-2007-1017072 · DOI
- Chen, 1994, Chronic sodium valproate selectively decreases protein kinase C alpha and epsilon in vitro, J Neurochem, 63, 2361, 10.1046/j.1471-4159.1994.63062361.x · DOI · Paper page
- Lenox, 1996, Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?, J Clin Psychiatry, 57, 23
- Manji, 1996, Regulation of signal transduction pathways by mood-stabilizing agents: implications for the delayed onset of therapeutic efficacy, J Clin Psychiatry, 57, 34
- Jope, 1999, Anti-bipolar therapy: mechanism of action of lithium, Mol Psychiatry, 4, 117, 10.1038/sj.mp.4000494 · DOI · Paper page
- Williams, 2002, A common mechanism of action for three mood-stabilizing drugs, Nature, 417, 292, 10.1038/417292a · DOI · Paper page
- Hall, 2002, Valproate regulates GSK-3-mediated axonal remodeling and synapsin i clustering in developing neurons, Mol Cell Neurosci, 20, 257, 10.1006/mcne.2002.1117 · DOI · Paper page
- Amari, 1999, Comparison of fluorescence, (31)P NMR, and (7)Li NMR spectroscopic methods for investigating Li(+)/Mg(2+) competition for biomolecules, Anal Biochem, 272, 1, 10.1006/abio.1999.4169 · DOI
- Ryves, 2001, Lithium inhibits glycogen synthase kinase-3 by competition for magnesium, Biochem Biophys Res Commun, 280, 720, 10.1006/bbrc.2000.4169 · DOI · Paper page
- Davies, 2000, Specificity and mechanism of action of some commonly used protein kinase inhibitors, Biochem J, 351, 95, 10.1042/0264-6021:3510095 · doi:10.1042/0264-6021:3510095 · Paper page
- York, 1995, Definition of a metal-dependent/Li(+)-inhibited phosphomonoesterase protein family based upon a conserved three-dimensional core structure, Proc Natl Acad Sci USA, 92, 5149, 10.1073/pnas.92.11.5149 · DOI · Paper page
- Masuda, 2001, Phosphoglucomutase is an in vivo lithium target in yeast, J Biol Chem, 10, 10
- Klein, 1996, A molecular mechanism for the effect of lithium on development, Proc Natl Acad Sci USA, 93, 8455, 10.1073/pnas.93.16.8455 · DOI · Paper page
- Li, 2002, Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders?, J Affect Disord, 69, 1, 10.1016/S0165-0327(00)00361-X · DOI
- Post, 1998, A history of the use of anticonvulsants as mood stabilizers in the last two decades of the 20th century, Neuropsychobiology, 38, 152, 10.1159/000026532 · DOI · Paper page
- Manji, 1992, G proteins: implications for psychiatry, Am J Psychiatry, 149, 746, 10.1176/ajp.149.6.746 · DOI · Paper page
- Casebolt, 1990, Alpha-1 adrenergic receptor binding and adrenergic-stimulated cyclic AMP production in rat cerebral cortex after chronic lithium treatment, J Neural Transm Gen Sect, 82, 197, 10.1007/BF01272762 · doi:10.1007/bf01272762
- Colin, 1991, Chronic lithium regulates the expression of adenylate cyclase and Gi- protein alpha subunit in rat cerebral cortex, Proc Natl Acad Sci USA, 88, 10634, 10.1073/pnas.88.23.10634 · DOI
- Jakobsen, 1998, Selective effects of long-term lithium and carbamazepine administration on G-protein subunit expression in rat brain, Brain Res, 780, 46, 10.1016/S0006-8993(97)01181-5 · doi:10.1016/s0006-8993(97)01181-5
- Li, 1993, Effects of chronic lithium and carbamazepine treatment on G-protein subunit expression in rat cerebral cortex, Biol Psychiatry, 34, 162, 10.1016/0006-3223(93)90387-S · DOI
- Masana, 1992, In vivo evidence that lithium inactivates Gi modulation of adenylate cyclase in brain, J Neurochem, 59, 200, 10.1111/j.1471-4159.1992.tb08891.x · DOI
- Ebstein, 1986, The cyclic AMP second messenger system in man: the effects of heredity, hormones, drugs, aluminum, age and disease on signal amplification, Prog Neuropsychopharmacol Biol Psychiatry, 10, 323, 10.1016/0278-5846(86)90011-4 · DOI
- Newman, 1992, Platelet adenylate cyclase activity in depression and after clomipramine and lithium treatment: relation to serotonergic function, Psychopharmacology, 109, 231, 10.1007/BF02245505 · DOI
- Risby, 1991, The mechanisms of action of lithium. II. Effects on adenylate cyclase activity and beta-adrenergic receptor binding in normal subjects, Arch Gen Psychiatry, 48, 513, 10.1001/archpsyc.1991.01810300025004 · DOI
- Ebstein, 1987, Effect of lithium in vitro and after chronic treatment on human platelet adenylate cyclase activity: postreceptor modification of second messenger signal amplification, Psychiatry Res, 21, 221, 10.1016/0165-1781(87)90026-6 · doi:10.1016/0165-1781(87)90026-6
- Hsiao, 1992, Lithium administration modulates platelet Gi in humans, Life Sci, 50, 227, 10.1016/0024-3205(92)90276-U · DOI
- Lonati-Galligani, 1989, Effect of in vivo lithium treatment on (−)isoproterenol-stimulated cAMP accumulation in lymphocytes of healthy subjects and patients with affective psychoses, Pharmacopsychiatry, 22, 241, 10.1055/s-2007-1014607 · doi:10.1055/s-2007-1014607
- Wang, 1974, Effect of lithium on prostaglandin F1-stimulated adenylate cyclase activity of human platelets, Biochem Pharmacol, 23, 845, 10.1016/0006-2952(74)90215-9 · doi:10.1016/0006-2952(74)90215-9
- Garcia-Sevilla, 1986, Biochemical and functional evidence of supersensitive platelet alpha 2-adrenoceptors in major affective disorder. Effect of long-term lithium carbonate treatment, Arch Gen Psychiatry, 43, 51, 10.1001/archpsyc.1986.01800010053007 · DOI
- Kofman, 1998, Lithium, but not carbamazepine, potentiates hyperactivity induced by intra-accumbens cholera toxin, Pharmacol Biochem Behav, 59, 191, 10.1016/S0091-3057(97)00410-3 · DOI
- Miki, 2001, Effects of subchronic lithium chloride treatment on G-protein subunits (Golf, Ggamma7) and adenylyl cyclase expressed specifically in the rat striatum, Eur J Pharmacol, 428, 303, 10.1016/S0014-2999(01)01343-7 · doi:10.1016/s0014-2999(01)01343-7
- Herve, 1993, G(olf) and Gs in rat basal ganglia: possible involvement of G(olf) in the coupling of dopamine D1 receptor with adenylyl cyclase, J Neurosci, 13, 2237, 10.1523/JNEUROSCI.13-05-02237.1993 · DOI · Paper page
- Manji, 1995, Signal transduction pathways. Molecular targets for lithium's actions, Arch Gen Psychiatry, 52, 531, 10.1001/archpsyc.1995.03950190013003 · DOI · Paper page
- Mork, 1992, Effects of lithium on second messenger systems in the brain, Pharmacol Toxicol, 71, 4, 10.1111/j.1600-0773.1992.tb01624.x · DOI
- Chen, 2000, Lithium regulates PKC-mediated intracellular cross-talk and gene expression in the CNS in vivo, Bipolar Disord, 2, 217, 10.1034/j.1399-5618.2000.20303.x · DOI · Paper page
- Manji, 1995, Guanine nucleotide-binding proteins in bipolar affective disorder. Effects of long-term lithium treatment, Arch Gen Psychiatry, 52, 135, 10.1001/archpsyc.1995.03950140053007 · DOI
- Jope, 1999, A bimodal model of the mechanism of action of lithium, Mol Psychiatry, 4, 21, 10.1038/sj.mp.4000444 · DOI
- Wiborg, 1999, Region-selective effects of long-term lithium and carbamazepine administration on cyclic AMP levels in rat brain, Pharmacol Toxicol, 84, 88, 10.1111/j.1600-0773.1999.tb00879.x · DOI
- Manji, 2000, Post-receptor signaling pathways in the pathophysiology and treatment of mood disorders, Curr Psychiatry Rep, 2, 479, 10.1007/s11920-000-0006-6 · DOI
- Ram, 1997, No abnormality in the gene for the G protein stimulatory alpha subunit in patients with bipolar disorder, Arch Gen Psychiatry, 54, 44, 10.1001/archpsyc.1997.01830130048010 · doi:10.1001/archpsyc.1997.01830130048010
- Ambrosio, 2002, Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024, Neurochem Res, 27, 121, 10.1023/A:1014814924965 · DOI · Paper page
- Palmer, 1979, Interactions of antiepileptic drugs on adenylate cyclase and phosphodiesterases in rat and mouse cerebrum, Exp Neurol, 63, 322, 10.1016/0014-4886(79)90128-6 · doi:10.1016/0014-4886(79)90128-6
- Palmer, 1979, Anticonvulsant drug actions on in vitro and in vivo levels of cyclic AMP in the mouse brain, Epilepsia, 20, 95, 10.1111/j.1528-1157.1979.tb04782.x · doi:10.1111/j.1528-1157.1979.tb04782.x
- Elphick, 1990, Chronic carbamazepine down-regulates adenosine A2 receptors: studies with the putative selective adenosine antagonists PD115,199 and PD116,948, Psychopharmacology, 100, 522, 10.1007/BF02244006 · doi:10.1007/bf02244006
- Van Calker, 1991, Carbamazepine distinguishes between adenosine receptors that mediate different second messenger responses, Eur J Pharmacol, 206, 285, 10.1016/0922-4106(91)90111-T · DOI
- Lewin, 1977, Cyclic AMP accumulation in cerebral cortical slices: effect of carbamazepine, phenobarbital, and phenytoin, Epilepsia, 18, 237, 10.1111/j.1528-1157.1977.tb04472.x · doi:10.1111/j.1528-1157.1977.tb04472.x
- Ferrendelli, 1979, Inhibitory effects of anticonvulsant drugs on cyclic nucleotide accumulation in brain, Ann Neurol, 5, 533, 10.1002/ana.410050606 · doi:10.1002/ana.410050606
- Avissar, 1990, Carbamazepine and electroconvulsive shock attenuate beta-adrenoceptor and muscarinic cholinoceptor coupling to G proteins in rat cortex, Eur J Pharmacol, 189, 99, 10.1016/0922-4106(90)90235-P · DOI
- Chen, 1996, Attenuation of cyclic AMP production by carbamazepine, J Neurochem, 67, 2079, 10.1046/j.1471-4159.1996.67052079.x · DOI · Paper page
- Divish, 1991, Differential effect of lithium on fos protooncogene expression mediated by receptor and postreceptor activators of protein kinase C and cyclic adenosine monophosphate: model for its antimanic action, J Neurosci Res, 28, 40, 10.1002/jnr.490280105 · doi:10.1002/jnr.490280105
- Ludvig, 1992, Dibutyryl cyclic AMP has epileptogenic potential in the hippocampus of freely behaving rats: a combined EEG-intracerebral microdialysis study, Neurosci Lett, 141, 187, 10.1016/0304-3940(92)90891-A · DOI
- Chen, 1996, Effects of valproic acid on beta-adrenergic receptors, G-proteins, and adenylyl cyclase in rat C6 glioma cells, Neuropsychopharmacology, 15, 271, 10.1016/0893-133X(95)00207-T · DOI
- Hudson, 1993, CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia, Synapse, 13, 278, 10.1002/syn.890130311 · DOI · Paper page
- Hallcher, 1980, The effects of lithium ion and other agents on the activity of myo- inositol-1-phosphatase from bovine brain, J Biol Chem, 255, 10896, 10.1016/S0021-9258(19)70391-3 · DOI · Paper page
- Naccarato, 1974, Biosynthesis of myo-inositol in rat mammary gland. Isolation and properties of the enzymes, Arch Biochem Biophys, 164, 194, 10.1016/0003-9861(74)90022-8 · DOI
- Majerus, 1992, Inositol phosphate biochemistry, Annu Rev Biochem, 61, 225, 10.1146/annurev.bi.61.070192.001301 · DOI · Paper page
- Berridge, 1989, Neural and developmental actions of lithium: a unifying hypothesis, Cell, 59, 411, 10.1016/0092-8674(89)90026-3 · DOI · Paper page
- Gani, 1993, Lithium and myo-inositol homeostasis, Biochim Biophys Acta, 1177, 253, 10.1016/0167-4889(93)90121-5 · DOI
- Allison, 1971, Reduced brain inositol in lithium-treated rats, Nat New Biol, 233, 267, 10.1038/newbio233267a0 · DOI · Paper page
- Moore, 1999, Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness, Am J Psychiatry, 156, 1902, 10.1176/ajp.156.12.1902 · DOI · Paper page
- Chen, 1999, Regulation of signal transduction pathways and gene expression by mood stabilizers and antidepressants, Psychosom Med, 61, 599, 10.1097/00006842-199909000-00004 · DOI
- Fauroux, 1999, Inhibitors of inositol monophosphatase, J Enzyme Inhib, 14, 97, 10.3109/14756369909036548 · DOI
- Godfrey, 1989, Subacute and chronic in vivo lithium treatment inhibits agonist- and sodium fluoride-stimulated inositol phosphate production in rat cortex, J Neurochem, 52, 498, 10.1111/j.1471-4159.1989.tb09148.x · doi:10.1111/j.1471-4159.1989.tb09148.x
- Song, 1992, Chronic lithium treatment impairs phosphatidylinositol hydrolysis in membranes from rat brain regions, J Neurochem, 58, 2200, 10.1111/j.1471-4159.1992.tb10964.x · DOI
- Manji, 1994, Long-term action of lithium: a role for transcriptional and posttranscriptional factors regulated by protein kinase C, Synapse, 16, 11, 10.1002/syn.890160103 · DOI · Paper page
- Jope, 1994, Lithium and brain signal transduction systems, Biochem Pharmacol, 47, 429, 10.1016/0006-2952(94)90172-4 · DOI · Paper page
- Vaden, 2001, Lithium and valproate decrease inositol mass and increase expression of the yeast INO1 and INO2 genes for inositol biosynthesis, J Biol Chem, 276, 15466, 10.1074/jbc.M004179200 · DOI
- Murray, 2000, Expression of yeast INM1 encoding inositol monophosphatase is regulated by inositol, carbon source and growth stage and is decreased by lithium and valproate, Mol Microbiol, 36, 651, 10.1046/j.1365-2958.2000.01886.x · DOI · Paper page
- van Calker, 2000, The high affinity inositol transport system – implications for the pathophysiology and treatment of bipolar disorder, Bipolar Disord, 2, 102, 10.1034/j.1399-5618.2000.020203.x · DOI
- Lubrich, 1999, Inhibition of the high affinity myo-inositol transport system: a common mechanism of action of antibipolar drugs?, Neuropsychopharmacology, 21, 519, 10.1016/S0893-133X(99)00037-8 · DOI · Paper page
- Coyle, 2002, Getting balance: drugs for bipolar disorder share target, Nat Med, 8, 557, 10.1038/nm0602-557 · DOI
- Manji, 1999, Ziskind-Somerfeld Research Award. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness, Biol Psychiatry, 46, 1328, 10.1016/S0006-3223(99)00235-8 · DOI · Paper page
- Manji, 1996, Modulation of protein kinase C isozymes and substrates by lithium: the role of myo-inositol, Neuropsychopharmacology, 15, 370, 10.1016/0893-133X(95)00243-7 · DOI
- Manji, 1993, Lithium decreases membrane-associated protein kinase C in hippocampus: selectivity for the alpha isozyme, J Neurochem, 61, 2303, 10.1111/j.1471-4159.1993.tb07474.x · DOI · Paper page
- Li, 1995, Selective inhibition of the expression of signal transduction proteins by lithium in nerve growth factor-differentiated PC12 cells, J Neurochem, 65, 2500, 10.1046/j.1471-4159.1995.65062500.x · DOI
- Lenox, 1992, Chronic lithium administration alters a prominent PKC substrate in rat hippocampus, Brain Res, 570, 333, 10.1016/0006-8993(92)90598-4 · DOI
- Watson, 1996, Chronic lithium-induced down-regulation of MARCKS in immortalized hippocampal cells: potentiation by muscarinic receptor activation, J Neurochem, 67, 767, 10.1046/j.1471-4159.1996.67020767.x · DOI · Paper page
- Watson, 1998, Sodium valproate down-regulates the myristoylated alanine-rich C kinase substrate (MARCKS) in immortalized hippocampal cells: a property of protein kinase C-mediated mood stabilizers, J Pharmacol Exp Ther, 285, 307
- Post, 1992, Sensitization, kindling, and carbamazepine: an update on their implications for the course of affective illness, Pharmacopsychiatry, 25, 41, 10.1055/s-2007-1014386 · DOI
- Steketee, 1991, Possible role for G-proteins in behavioral sensitization to cocaine, Brain Res, 545, 287, 10.1016/0006-8993(91)91299-G · DOI
- Steketee, 1991, Sensitization to psychostimulants and stress after injection of pertussis toxin into the A10 dopamine region, J Pharmacol Exp Ther, 259, 916
- Steketee, 1993, Injection of the protein kinase inhibitor H7 into the A10 dopamine region blocks the acute responses to cocaine: behavioral and in vivo microdialysis studies, Neuropharmacology, 32, 1289, 10.1016/0028-3908(93)90023-V · DOI
- Steketee, 1994, Intra-A10 injection of H7 blocks the development of sensitization to cocaine, Neuroreport, 6, 69, 10.1097/00001756-199412300-00019 · DOI · Paper page
- Giambalvo, 1992, Protein kinase C and dopamine transport – 2. Effects of amphetamine in vitro, Neuropharmacology, 31, 1211, 10.1016/0028-3908(92)90049-U · DOI
- Giambalvo, 1992, Protein kinase C and dopamine transport – 1. Effects of amphetamine in vivo, Neuropharmacology, 31, 1201, 10.1016/0028-3908(92)90048-T · DOI
- Gnegy, 1993, Phosphorylation of neuromodulin in rat striatum after acute and repeated, intermittent amphetamine, Brain Res Mol Brain Res, 20, 289, 10.1016/0169-328X(93)90055-T · DOI
- Iwata, 1997, Enhanced dopamine release and phosphorylation of synapsin I and neuromodulin in striatal synaptosomes after repeated amphetamine, J Pharmacol Exp Ther, 283, 1445
- Iwata, 1997, Amphetamine increases the phosphorylation of neuromodulin and synapsin I in rat striatal synaptosomes, Synapse, 26, 281, 10.1002/(SICI)1098-2396(199707)26:3<281::AID-SYN9>3.0.CO;2-3 · DOI · Paper page
- Daigen, 1991, Long-lasting enhancement of the membrane-associated protein kinase C activity in the hippocampal kindled rat, Jpn J Psychiatry Neurol, 45, 297
- Daigen, 1991, Long-lasting change in the membrane-associated protein kinase C activity in the hippocampal kindled rat, Brain Res, 545, 131, 10.1016/0006-8993(91)91278-9 · DOI
- Kantor, 1998, Protein kinase C inhibitors block amphetamine-mediated dopamine release in rat striatal slices, J Pharmacol Exp Ther, 284, 592
- Ur, 1992, Mania in association with hydrocortisone replacement for Addison's disease, Postgrad Med J, 68, 41, 10.1136/pgmj.68.795.41 · DOI
- Haskett, 1985, Diagnostic categorization of psychiatric disturbance in Cushing's syndrome, Am J Psychiatry, 142, 911, 10.1176/ajp.142.8.911 · DOI · Paper page
- Dwivedi, 1999, Administration of dexamethasone up-regulates protein kinase C activity and the expression of gamma and epsilon protein kinase C isozymes in the rat brain, J Neurochem, 72, 380, 10.1046/j.1471-4159.1999.0720380.x · DOI
- Nalepa, 1994, The responsiveness of cerebral cortical adrenergic receptors after chronic administration of atypical antidepressant mianserin, J Psychiatry Neurosci, 19, 120
- Nalepa, 1993, The antagonistic effect of separate and consecutive chronic treatment with imipramine and ECS on the inhibition of alpha 1-adrenoceptor activity by protein kinase C, Pol J Pharmacol, 45, 521
- Apparsundaram, 1998, Acute regulation of norepinephrine transport: II. PKC-modulated surface expression of human norepinephrine transporter proteins, J Pharmacol Exp Ther, 287, 744
- Apparsundaram, 1998, Acute regulation of norepinephrine transport: I. protein kinase C-linked muscarinic receptors influence transport capacity and transporter density in SK-N-SH cells, J Pharmacol Exp Ther, 287, 733
- Blakely, 1998, Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins, Biol Psychiatry, 44, 169, 10.1016/S0006-3223(98)00124-3 · DOI · Paper page
- Zhang, 1998, Expression and regulation of the human dopamine transporter in a neuronal cell line, Brain Res Mol Brain Res, 59, 66, 10.1016/S0169-328X(98)00138-7 · DOI
- Chen, 1997, Enhanced phosphorylation of the postsynaptic protein kinase C substrate RC3/neurogranin during long-term potentiation, Brain Res, 749, 181, 10.1016/S0006-8993(96)01159-6 · DOI
- Hahn, 1999, Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder, Bipolar Disord, 1, 81, 10.1034/j.1399-5618.1999.010204.x · DOI · Paper page
- Bebchuk, 2000, A preliminary investigation of a protein kinase C inhibitor in the treatment of acute mania, Arch Gen Psychiatry, 57, 95, 10.1001/archpsyc.57.1.95 · DOI
- Horgan, 1986, Inhibition of protein kinase C mediated signal transduction by tamoxifen. Importance for antitumour activity, Biochem Pharmacol, 35, 4463, 10.1016/0006-2952(86)90764-1 · DOI
- O'Brian, 1988, Specific and direct binding of protein kinase C to an immobilized tamoxifen analogue, Cancer Res, 48, 3626
- Cohen, 2001, The renaissance of GSK3, Nat Rev Mol Cell Biol, 2, 769, 10.1038/35096075 · DOI · Paper page
- Plyte, 1992, Glycogen synthase kinase-3: functions in oncogenesis and development, Biochim Biophys Acta, 1114, 147
- Woodgett, 2001, Judging a protein by more than its name: gsk-3, Sci STKE, 1, RE12
- Haugaard, 1974, Actions of lithium ions and insulin on glucose utilization, glycogen synthesis and glycogen synthase in the isolated rat diaphragm, Biochem Pharmacol, 23, 1675, 10.1016/0006-2952(74)90394-3 · DOI
- Cheng, 1983, ‘Insulin-like’ effects of lithium ion on isolated rat adipocytes. II. Specific activation of glycogen synthase, Mol Cell Biochem, 56, 183, 10.1007/BF00227219 · DOI
- Bosch, 1986, Effects of lithium ions on glycogen synthase and phosphorylase in rat hepatocytes, J Biol Chem, 261, 16927, 10.1016/S0021-9258(19)75978-X · DOI · Paper page
- Harwood, 2001, Regulation of GSK-3: a cellular multiprocessor, Cell, 105, 821, 10.1016/S0092-8674(01)00412-3 · DOI · Paper page
- Grimes, 2001, The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling, Prog Neurobiol, 65, 391, 10.1016/S0301-0082(01)00011-9 · DOI · Paper page
- Salinas, 1999, Lithium and synaptic plasticity, Bipolar Disord, 1, 87, 10.1034/j.1399-5618.1999.010205.x · DOI
- Gould, 2002, The Wnt signaling pathway in bipolar disorder, Neuroscientist, 8, 497, 10.1177/107385802237176 · DOI · Paper page
- Li, 2002, Glycogen synthase kinase 3-beta, mood stabilizers, and neuroprotection, Bipolar Disord, 4, 137, 10.1034/j.1399-5618.2002.40201.x · DOI · Paper page
- Manji, 2000, Neuroplasticity and cellular resilience in mood disorders, Mol Psychiatry, 5, 578, 10.1038/sj.mp.4000811 · DOI · Paper page
- Phiel, 2001, Molecular targets of lithium action, Annu Rev Pharmacol Toxicol, 41, 789, 10.1146/annurev.pharmtox.41.1.789 · DOI · Paper page
- Chen, 1999, The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3, J Neurochem, 72, 1327, 10.1046/j.1471-4159.2000.0721327.x · DOI · Paper page
- Grimes, 2001, CREB DNA binding activity is inhibited by glycogen synthase kinase-3beta and facilitated by lithium, J Neurochem, 78, 1, 10.1046/j.1471-4159.2001.00495.x · DOI · Paper page
- Axelrod, 1988, Receptor-mediated activation of phospholipase A2 via GTP-binding proteins: arachidonic acid and its metabolites as second messengers, Trends Neurosci, 11, 117, 10.1016/0166-2236(88)90157-9 · DOI · Paper page
- Rapoport, 2001, In vivo fatty acid incorporation into brain phospholipids in relation to plasma availability, signal transduction and membrane remodeling, J Mol Neurosci, 16, 243, 10.1385/JMN:16:2-3:243 · DOI · Paper page
- Axelrod, 1995, Phospholipase A2 and G proteins, Trends Neurosci, 18, 64, 10.1016/0166-2236(95)93873-V · doi:10.1016/0166-2236(95)93873-v
- Chang, 2001, Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers, J Neurochem, 77, 796, 10.1046/j.1471-4159.2001.00311.x · DOI · Paper page
- Chang, 1996, Lithium decreases turnover of arachidonate in several brain phospholipids, Neurosci Lett, 220, 171, 10.1016/S0304-3940(96)13264-X · DOI
- Rapoport, 2002, Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder?, Arch Gen Psychiatry, 59, 592, 10.1001/archpsyc.59.7.592 · DOI · Paper page
- Chang, 1998, Chronic lithium treatment decreases brain phospholipase A2 activity, Neurochem Res, 23, 887, 10.1023/A:1022415113421 · DOI
- Rintala, 1999, 85 kDa cytosolic phospholipase A2 is a target for chronic lithium in rat brain, Neuroreport, 10, 3887, 10.1097/00001756-199912160-00030 · DOI · Paper page
- Patapoutian, 2001, Trk receptors: mediators of neurotrophin action, Curr Opin Neurobiol, 11, 272, 10.1016/S0959-4388(00)00208-7 · DOI · Paper page
- Riccio, 1997, An NGF-TrkA-mediated retrograde signal to transcription factor CREB in sympathetic neurons, Science, 277, 1097, 10.1126/science.277.5329.1097 · DOI · Paper page
- Bonni, 1999, Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms, Science, 286, 1358, 10.1126/science.286.5443.1358 · DOI · Paper page
- Suzuki, 1995, ERK2-type mitogen-activated protein kinase (MAPK) and its substrates in postsynaptic density fractions from the rat brain, Neurosci Res, 22, 277, 10.1016/0168-0102(95)00902-6 · DOI
- Matsubara, 1996, Site-specific phosphorylation of synapsin I by mitogen-activated protein kinase and Cdk5 and its effects on physiological functions, J Biol Chem, 271, 21108, 10.1074/jbc.271.35.21108 · DOI · Paper page
- Kornhauser, 1997, A kinase to remember: dual roles for MAP kinase in long-term memory, Neuron, 18, 839, 10.1016/S0896-6273(00)80322-0 · DOI
- Fukunaga, 1998, Role of MAP kinase in neurons, Mol Neurobiol, 16, 79, 10.1007/BF02740604 · DOI · Paper page
- Robinson, 1998, A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation, Curr Biol, 8, 1141, 10.1016/S0960-9822(07)00485-X · DOI · Paper page
- Xu, 1997, Induction of mitogen-activated protein kinase phosphatase-1 during acute hypertension, Hypertension, 30, 106, 10.1161/01.HYP.30.1.106 · DOI
- Roberson, 1999, The mitogen-activated protein kinase cascade couples PKA and PKC to cAMP response element binding protein phosphorylation in area CA1 of hippocampus, J Neurosci, 19, 4337, 10.1523/JNEUROSCI.19-11-04337.1999 · DOI · Paper page
- Roberson, 1996, A biochemist's view of long-term potentiation, Learn Mem, 3, 1, 10.1101/lm.3.1.1 · DOI · Paper page
- Chen, 1999, The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS, J Neurochem, 72, 879, 10.1046/j.1471-4159.1999.720879.x · DOI · Paper page
- Manji, 1999, Lithium at 50: have the neuroprotective effects of this unique cation been overlooked?, Biol Psychiatry, 46, 929, 10.1016/S0006-3223(99)00165-1 · DOI · Paper page
- Chen, 1999, Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity, J Biol Chem, 274, 6039, 10.1074/jbc.274.10.6039 · DOI · Paper page
- Fukumoto, 2001, Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain, Psychopharmacology (Berl), 158, 100, 10.1007/s002130100871 · DOI · Paper page
- Chen, 2002, Evidence for the Involvement of the ERK MAP kinase signaling cascade in mood modulation, Biol Psychiatry, 51, 3685
- Yuan, 2001, The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth, J Biol Chem, 276, 31674, 10.1074/jbc.M104309200 · DOI · Paper page
- Chuang, 2002, Neuroprotective effects of lithium in cultured cells and animal model of diseases, Bipolar Disord, 4, 129, 10.1034/j.1399-5618.2002.01179.x · DOI · Paper page
- Jope, 2002, Mood stabilizers, glycogen synthase kinase-3b and cell survival, Mol Psychiatry, 7, S35, 10.1038/sj.mp.4001017 · DOI
- Inouye, 1995, Lithium delays the radiation-induced apoptotic process in external granule cells of mouse cerebellum, J Radiat Res (Tokyo), 36, 203, 10.1269/jrr.36.203 · doi:10.1269/jrr.36.203
- Grignon, 1996, Tyrosine kinase inhibitors and cycloheximide inhibit Li+ protection of cerebellar granule neurons switched to non-depolarizing medium, Eur J Pharmacol., 315, 111, 10.1016/S0014-2999(96)00591-2 · DOI
- Li, R., Shen Y, El-Mallakh RS. Lithium protects against ouabain-induced cell death. Lithium 1994;5(4):211-216.
- Volonte, 1993, Lithium chloride promotes short-term survival of PC12 cells after serum and NGF deprivation, Lithium, 4, 211
- D'Mello, 1994, Lithium induces apoptosis in immature cerebellar granule cells but promotes survival of mature neurons, Exp Cell Res, 211, 332, 10.1006/excr.1994.1095 · DOI
- Manji, 2000, Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness, Biol Psychiatry, 48, 740, 10.1016/S0006-3223(00)00979-3 · DOI · Paper page
- Rajkowska, 2000, Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells, Biol Psychiatry, 48, 766, 10.1016/S0006-3223(00)00950-1 · DOI · Paper page
- Rajkowska, 2002, Cell pathology in bipolar disorder, Bipolar Disord, 4, 105, 10.1034/j.1399-5618.2002.01149.x · DOI · Paper page
- Harrison, 2002, The neuropathology of primary mood disorder, Brain, 125, 1428, 10.1093/brain/awf149 · DOI · Paper page
- Wei, 2001, Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington's disease, Neuroscience, 106, 603, 10.1016/S0306-4522(01)00311-6 · DOI · Paper page
- Nonaka, 1998, Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats, Neuroreport, 9, 2081, 10.1097/00001756-199806220-00031 · DOI · Paper page
- Bruno, 1995, Antidegenerative effects of Mg(2+)-valproate in cultured cerebellar neurons, Funct Neurol, 10, 121
- Mark, 1995, Anticonvulsants attenuate amyloid beta-peptide neurotoxicity, Ca2+ deregulation, and cytoskeletal pathology, Neurobiol Aging, 16, 187, 10.1016/0197-4580(94)00150-2 · DOI
- Mora, 1999, Different mechanisms of protection against apoptosis by valproate and Li+, Eur J Biochem, 266, 886, 10.1046/j.1432-1327.1999.00919.x · DOI · Paper page
- Hashimoto, 2002, Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation, J Neurochem, 80, 589, 10.1046/j.0022-3042.2001.00728.x · DOI · Paper page
- Bijur, 2000, Glycogen synthase kinase-3beta facilitates staurosporine- and heat shock-induced apoptosis. Protection by lithium, J Biol Chem, 275, 7583, 10.1074/jbc.275.11.7583 · DOI · Paper page
- Inestrosa, 2000, Acetylcholinesterase-amyloid-beta-peptide interaction and Wnt signaling involvement in Abeta neurotoxicity, Acta Neurol Scand Suppl, 176, 53, 10.1034/j.1600-0404.2000.00308.x · DOI · Paper page
- Dong, 1994, Effects of carbamazepine on hypoxic and ischemic brain damage in mice [in Chinese], Zhongguo Yao Li Xue Bao, 15, 257
- Moore, 2000, Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2’s neurotrophic effects?, Biol Psychiatry, 48, 1, 10.1016/S0006-3223(00)00252-3 · DOI · Paper page
- Soares, 2002, Can brain-imaging studies provide a ‘mood stabilizer signature’?, Mol Psychiatry, 71, S64, 10.1038/sj.mp.4001020 · DOI
- Cade, 1949, Lithium salts in the treatment of psychotic excitement, Med J Austr, 2, 349, 10.5694/j.1326-5377.1949.tb36912.x · DOI · Paper page
- Lenox, 2000, Overview of the mechanism of action of lithium in the brain: fifty-year update, J Clin Psychiatry, 61, 5
- Shaldubina, 2001, The mechanism of lithium action: state of the art, ten years later, Prog Neuropsychopharmacol Biol Psychiatry, 25, 855, 10.1016/S0278-5846(01)00154-3 · DOI
- Nakashima, 1976, Size-dependent allosteric effects of monovalent cations on rabbit liver fructose-1,6-bisphosphatase, J Biol Chem, 251, 4315, 10.1016/S0021-9258(17)33298-2 · doi:10.1016/s0021-9258(17)33298-2
- Nordenberg, 1982, Effects of lithium on the activities of phosphofructokinase and phosphoglucomutase and on glucose-1,6-diphosphate levels in rat muscles, brain and liver, Biochem Pharmacol, 31, 1025, 10.1016/0006-2952(82)90338-0 · DOI
- Yenush, 2000, A novel target of lithium therapy, FEBS Lett, 467, 321, 10.1016/S0014-5793(00)01183-2 · DOI
- Rhyu, 1984, Enzyme-bound intermediates in the conversion of glucose 1-phosphate to glucose 6-phosphate by phosphoglucomutase. Phosphorus NMR studies, Biochemistry, 23, 252, 10.1021/bi00297a013 · doi:10.1021/bi00297a013
- Ray, 1978, The binding of lithium and of anionic metabolites to phosphoglucomutase, Biochim Biophys Acta, 522, 434, 10.1016/0005-2744(78)90076-1 · DOI
- Martinez, 2002, Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation, Med Res Rev, 22, 373, 10.1002/med.10011 · DOI · Paper page
- Emrich, 1980, Effect of sodium valproate on mania. The GABA-hypothesis of affective disorders, Arch Psychiatr Nervenkr, 229, 1, 10.1007/BF00343800 · DOI · Paper page
- Lambert, 1987, Use of valpromide in psychiatric therapeutics [in French], Encephale, 13, 367
- Bowden, 1994, Efficacy of divalproex vs. lithium and placebo in the treatment of mania. The Depakote Mania Study Group, J Am Med Assoc, 271, 918, 10.1001/jama.1994.03510360044034 · DOI · Paper page
- Pope, 1991, Valproate in the treatment of acute mania. A placebo-controlled study, Arch Gen Psychiatry, 48, 62, 10.1001/archpsyc.1991.01810250064008 · DOI · Paper page
- Lemperiere, 2001, Brief history of the development of valproate in bipolar disorders [in French], Encephale, 27, 365
- Lambert, 1992, Comparative study of valpromide versus lithium in the treatment of affective disorders, Nervure, 5, 57
- Macdonald, 1995, Antiepileptic drug mechanisms of action, Epilepsia, 36, S2, 10.1111/j.1528-1157.1995.tb05996.x · DOI · Paper page
- Johannessen, 2000, Mechanisms of action of valproate: a commentary, Neurochem Int, 37, 103, 10.1016/S0197-0186(00)00013-9 · DOI · Paper page
- van der Laan, 1979, Di-n-propylacetate and GABA degradation. Preferential inhibition of succinic semialdehyde dehydrogenase and indirect inhibition of GABA-transaminase, J Neurochem, 32, 1769, 10.1111/j.1471-4159.1979.tb02290.x · doi:10.1111/j.1471-4159.1979.tb02290.x
- Anlezark, 1976, Proceedings: gamma-Aminobutyric acid metabolism and the anticonvulsant action of ethanolamine-o-sulphate and di-n-propylacetate, Br J Pharmacol, 56, 383
- Sawaya, 1975, Effects of anticonvulsant drugs on the cerebral enzymes metabolizing GABA, Epilepsia, 16, 649, 10.1111/j.1528-1157.1975.tb04747.x · doi:10.1111/j.1528-1157.1975.tb04747.x
- Whittle, 1978, Effects of the anticonvulsant sodium valproate on gamma-aminobutyrate and aldehyde metabolism in ox brain, J Neurochem, 31, 1453, 10.1111/j.1471-4159.1978.tb06572.x · doi:10.1111/j.1471-4159.1978.tb06572.x
- Balazs, 1970, The operation of the gamma-aminobutyrate bypath of the tricarboxylic acid cycle in brain tissue in vitro, Biochem J, 116, 445, 10.1042/bj1160445 · DOI · Paper page
- Leiderman, 1991, Effect of valproate on human cerebral glucose metabolism, Epilepsia, 32, 417, 10.1111/j.1528-1157.1991.tb04671.x · DOI · Paper page
- Gaillard, 1996, Effect of valproate on cerebral metabolism and blood flow: an 18F-2-deoxyglucose and 15O water positron emission tomography study, Epilepsia, 37, 515, 10.1111/j.1528-1157.1996.tb00602.x · DOI · Paper page
- Godin, 1969, Effects of DI-n-propylacetate, and anticonvulsive compound, on GABA metabolism, J Neurochem, 16, 869, 10.1111/j.1471-4159.1969.tb08975.x · DOI · Paper page
- Loscher, 1993, Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain, Neurochem Res, 18, 485, 10.1007/BF00967253 · DOI
- Gottlicher, 2001, Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells, EMBO J, 20, 6969, 10.1093/emboj/20.24.6969 · DOI · Paper page
- Loscher, 1985, Pharmacological evaluation of various metabolites and analogues of valproic acid. Anticonvulsant and toxic potencies in mice, Neuropharmacology, 24, 427, 10.1016/0028-3908(85)90028-0 · DOI
- Radatz, 1998, Valnoctamide, valpromide and valnoctic acid are much less teratogenic in mice than valproic acid, Epilepsy Res, 30, 41, 10.1016/S0920-1211(97)00095-8 · doi:10.1016/s0920-1211(97)00095-8
- Lampen, 1999, New molecular bioassays for the estimation of the teratogenic potency of valproic acid derivatives in vitro: activation of the peroxisomal proliferator-activated receptor (PPARdelta), Toxicol Appl Pharmacol, 160, 238, 10.1006/taap.1999.8770 · DOI
200 of 224 shown
Cited by
Cryan, J. F., Mombereau, C., & Vassout, A. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.009 · Cited by 1,674
Lithium induces autophagy by inhibiting inositol monophosphatase
Sarkar, S., Floto, R. A., Berger, Z., Imarisio, S., Cordenier, A., Pasco, M., Cook, L. J., & Rubinsztein, D. C. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200504035 · Cited by 985
“Lithium inhibits a number of enzymes, including glycogen synthase kinase-3 (GSK-3 ) and IMPase (Gould et al., 2002; Coyle and Duman, 2003).”
BackgroundInfluentialThe Role of the Extracellular Signal-Regulated Kinase Signaling Pathway in Mood Modulation
Einat, H., Yuan, P., Gould, T. D., Li, J., Du, J., Zhang, L., Manji, H. K., & Chen, G. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-19-07311.2003 · Cited by 481
Self-citationPotential Mechanisms of Action of Lithium in Bipolar Disorder: Current Understanding
Malhi, G. S., Tanious, M., Das, P., Coulston, C. M., & Berk, M. (2013) · CNS Drugs · doi:10.1007/s40263-013-0039-0 · Cited by 453
Mood Stabilizer Valproate Promotes ERK Pathway-Dependent Cortical Neuronal Growth and Neurogenesis
Hao, Y., Creson, T., Zhang, L., Li, P., Du, F., Yuan, P., Gould, T. D., Manji, H. K., & Chen, G. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5747-03.2004 · Cited by 404
Self-citation
Metadata
- Authors
- Gould, T. D., Chen, G., & Manji, H. K.
- Venue
- Clinical Neuroscience Research
- Publisher
- Elsevier BV
- Published
- 2002-12
- Volume
- 2
- Issue
- 3-4
- Pages
- 193-212
- ISSN
- 1566-2772
- Cited by
- 47
- References
- 9
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mood stabilizer psychopharmacology. https://app.cochat.ai/papers/10.1016/s1566-2772(02)00044-0
- The paper
- Gould, T. D., Chen, G., & Manji, H. K. (2002). Mood stabilizer psychopharmacology. Clinical Neuroscience Research. https://doi.org/10.1016/s1566-2772(02)00044-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.